🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 87978U108 (prev. 60040X103 )
- Market Cap
- Micro Cap
- IPO
- 4/30/2013
- Previous Symbol
- MLND (changed 6/28/2021)
- Previous Name
- Millendo Therapeutics, Inc.
Business: Tempest Therapeutics is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
Notes: June 28, 2021 -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, announced today the closing of its merger with Millendo Therapeutics, Inc. (“Millendo”). Tempest’s stock will commence trading on June 28, 2021 on the Nasdaq Global Select Market under the trading symbol “TPST.”
Company Contact
- CEO
- Matt Angel
- CFO
- Justin Trojanowski
- Headquarters
- 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94002
- Phone
- 415-798-8589
- Investor Relations
- Sylvia Wheeler, Wheeler Life Science Advisors · swheeler@wheelhouselsa.com